Bicara Therapeutics Inc. (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

26.88

-0.93 (-3.34%)

At close: Jul 28, 2026, 4:00 PM EDT

26.88

0.00 (0.00%)

After-hours: Jul 28, 2026, 4:10 PM EDT

Bicara Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Income	-174.06	-155.6	-82.39	-39.89	-37.66
Net Income	-157.32	-137.95	-68	-51.99	-37.85
Earnings Per Share	-2.78	-2.52	-4.05	-89.61	-88.20
EPS Growth	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	539.75	414.8	489.71	230.44	4.16
Total Debt	1.44	1.71	0.74	0.66	0
Net Cash (Debt)	538.31	413.09	488.97	229.78	4.16
Net Cash Growth	16.65%	-15.52%	112.80%	5426.29%	-
Net Cash Per Share	9.57	7.56	29.10	396.10	9.69

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-116.24	-106.83	-74.75	-45.63	-32.08
Capital Expenditures	-	-0.28	-0.07	-0.59	-0.19
Free Cash Flow	-116.24	-107.11	-74.82	-46.21	-32.27
Free Cash Flow Growth	-	-	-	-	-